Correlation analysis between echocardiographic flow pattern and N-terminal-pro-brain natriuretic peptide for early targeted treatment of patent ductus arteriosus

References

• Clyman RI, Couto J, Murphy GM. Patent ductus arteriosus: are current neonatal treatment options better or worse than no treatment at all? Semin Perinatol 2012;36:123–9
   PubMed Web of Science ®Google Scholar
• Koch J, Hensley G, Roy L, et al. Prevalence of spontaneous closure of the ductus arteriosus in neonates at a birth weight of 1000 grams or less. Pediatrics 2006;117:1113–21
   PubMed Web of Science ®Google Scholar
• Evans N. Preterm patent ductus arteriosus: should we treat it? J Paediatr Child Health 2012;48:753–8
   Google Scholar
• Kluckow M, Jeffery M, Gill A, Evans N. A randomised placebo-controlled trial of early treatment of the patent ductus arteriosus. Arch Dis Child Fetal Neonatal Ed 2013. [Epub ahead of print]. doi:10.1136/archdischild-2013-304695
   Google Scholar
• Su BH, Peng CT, Tsa CH. Echocardiographic flow pattern of patent ductus arteriosus: a guide to indomethacin treatment in premature infants. Arch Dis Child Fetal Neonatal Ed 1999;81:197–200
   PubMed Web of Science ®Google Scholar
• Skelton R, Evans N, Smythe J. A blinded comparison of clinical and echocardiographic evaluation of the preterm infant for patent ductus arteriosus. J Paediatr Child Health 1994;30:406–11
   PubMed Web of Science ®Google Scholar
• Su BH, Watanabe T, Shimizu M, Yanagisawa M. Echocardiographic assessment of patent ductus arteriosus shunt flow pattern in premature infants. Arch Dis Child 1997;77:36–40
   Google Scholar
• Sehgal A, McNamara PJ. Does echocardiography facilitate determination of hemodynamic significance attributable to the ductus arteriosus? Eur J Pediatr 2009;28:729–35
   Google Scholar
• El-Khuffash AF, Amoruso M, Culliton M, Molloy EJ. N-terminal pro-B-type natriuretic peptide as a marker of ductal haemodynamic significance in preterm infants: a prospective observational study. Arch Dis Child Fetal Neonatal Ed 2007;92:421–2
   PubMedGoogle Scholar
• Farombi-Oghuvbu I, Matthews T, Mayne PD, et al. NT-proBNP: a measure of significant patent ductus arteriosus. Arch Dis Child Fetal Neonatal Ed 2008;93:257–60
   Google Scholar
• Martinovici D, Vanden Eijnden S, Unger P, et al. Early NT-proBNP is able to predict spontaneous closure of patent ductus arteriosus in preterm neonates, but not the need of its treatment. Pediatr Cardiol 2011;32:953–7
   Google Scholar
• Nuntnarumit P, Khositsethand A, Thanomsingh P. NT-proBNP and patent ductus arteriosus in preterminfants. J Perinatol 2009;29:137–42
   Google Scholar
• Ramakrishnan S, Heung YM, Round J, et al. Early NT-proBNP measurements predict clinically significant ductus arteriosus in preterm infants. Acta Paediatr 2009;98:1254–9
   Google Scholar
• Hung J, Lang R, Flachskampf F, et al. 3D echocardiography: a review of the current status and future directions. J Am Soc Echocardiogr 2007;20:213–33
   PubMed Web of Science ®Google Scholar
• El Hajjar M, Vaksmann G, Rakza T, et al. Severity of the ductal shunt: a comparison of different markers. Arch Dis Child Fetal Neonatal Ed 2005;90:419–22
   PubMed Web of Science ®Google Scholar
• Hamrick SE, Hansmann G. Patent ductus arteriosus of the preterm infant. Pediatrics 2010;125:1020–30
   PubMed Web of Science ®Google Scholar
• Condò M, Evans N, Bellù R, Kluckow M. Echocardiographic assessment of ductal significance: retrospective comparison of two methods. Arch Dis Child Fetal Neonatal Ed 2012;97:35–8
   Google Scholar
• El-Khuffash A, Molloy E. The use of N-terminal-Pro-BNP in preterm infants. Int J Pediatr 2009;2009: article ID 175216:1--7
   Google Scholar
• Evans N. Diagnosis of the preterm patent ductus arteriosus: clinical signs, biomarkers, or ultrasound? Semin Perinatol 2012;36:114–22
   PubMedGoogle Scholar
• Kluckow M, Seri I, Evans N. Functional echocardiography: an emerging clinical tool for the neonatologist. J Pediatr 2007;150:125–30
   PubMed Web of Science ®Google Scholar
• Nir A, Lindinger A, Rauh M, et al. NT-Pro-B-type natriuretic peptide in infants and children: reference values based on combined data from four studies. Pediatr Cardiol 2009;30:3–8
   PubMed Web of Science ®Google Scholar
• Letzner J, Berger F, Schwabe S, et al. Plasma C-terminal pro-endothelin-1 and the natriuretic pro-peptides NT-proBNP and MR-proANP in very preterm infants with patent ductus arteriosus. Neonatology 2012;101:116–24
   Google Scholar
• Seong WJ, Yoon DH, Chong GO, et al. Umbilical cord blood amino-terminal pro-brain natriuretic peptide levels according to the mode of delivery. Arch Gynecol Obstet 2010;281:907–12
   PubMedGoogle Scholar
• Cambonie G, Dupuy AM, Combes C, et al. Can a clinical decision rule help ductus arteriosus management in preterm neonates? Acta Paediatr 2012;101:e213–8
   Google Scholar
• Chen S, Tacy T, Clyman R. How useful are B-type natriuretic peptide measurements for monitoring changes in patent ductus arteriosus shunt magnitude? J Perinatol 2010;30:780–5
   Web of Science ®Google Scholar
• Mir TS, Laux R, Hellwege HH, et al. Plasma concentrations of aminoterminal pro atrial natriuretic peptide and aminoterminal pro brain natriuretic peptide in healthy neonates: marked and rapid increase after birth. Pediatrics 2003;112:896–9
   PubMed Web of Science ®Google Scholar